Treatment
Cannabidiol clinical trials
We’re tracking 66 recruiting studies that include Cannabidiol, each written for real people, not researchers, below.
Recruiting studies
- NCT07271030Recruiting
Cannabidiol suppositories for sexual pain
This trial studies whether cannabidiol (CBD) suppositories can help with pain during sex. If you have sexual pain and have used CBD before without a reaction, you may be able to join.
LondonAges 18–100 - NCT07123467RecruitingPhase 3
Study on CBD and learning for generalized anxiety
This trial tests if adding cannabidiol (CBD) to a learning-based approach helps manage generalized anxiety disorder (GAD). It involves brain scans and taking CBD daily.
Detroit, MichiganAges 18–45 - NCT04587791RecruitingEarly Phase 1
Cannabidiol (CBD) for opioid use disorder and chronic pain
This early study tests whether CBD can reduce symptoms of chronic pain in people receiving opioid maintenance treatment for opioid use disorder. It also looks at safety and whether CBD can be added without causing major problems.
West Haven, ConnecticutAges 18–70 - NCT06629389RecruitingPhase 2
Cannabidiol (Kanbis) for Parkinson's symptoms
This trial tests whether cannabidiol (CBD) can help with Parkinson's disease symptoms. Researchers want to see if it's safe and effective for people with mild to moderate Parkinson's who are already on stable medications.
Mendoza, Mendoza ProvinceAges 40–80 - NCT06686914RecruitingPhase 1
How CBD affects driving by dose and sex
This study tests how different doses of CBD (a cannabis compound) affect driving ability in healthy adults. It looks at whether men and women react differently, and helps understand if CBD is safe to use before driving.
Morgantown, West VirginiaAges 18–30 - NCT07434895RecruitingEarly Phase 1
Can CBD Change How You Use Cannabis?
This study looks at how taking CBD (a cannabis compound that doesn't get you high) affects your cannabis use. It is for healthy adults who use cannabis for recreational reasons, not for medical treatment.
Lexington, KentuckyAges 18–55 - NCT06575751RecruitingPhase 2
Study of cannabidiol and cannabis concentrate users
This study looks at how cannabidiol (a compound in cannabis) affects people who regularly use strong cannabis concentrates like wax, shatter, or oil. It may help understand if using CBD can change how cannabis affects the body or help with cannabis use disorder.
Aurora, ColoradoAges 25–60 - NCT05445804RecruitingPhase 1
Oral cannabidiol (CBD) to help you quit tobacco
This Phase 1 study tests whether taking oral CBD can help people quit tobacco. It also checks safety and helps researchers learn how people respond to the treatment while they practice quitting.
Baltimore, MarylandAges 18–65 - NCT06290063RecruitingPhase 2
CBD for older adults who use cannabis
This study tests whether a pure CBD product (Epidiolex) can help older adults who use cannabis occasionally. It looks at how CBD affects people who already take medications for pain, sleep, or mood issues.
Boulder, ColoradoAges 60 years+ - NCT07279558RecruitingPhase 2
CBD and Alcohol Use Study
This study tests whether cannabidiol (CBD), a compound from cannabis, can help people who drink alcohol regularly reduce their drinking or change their drinking patterns. You may be eligible if you're 21-65, have used CBD or cannabis before, drink alcohol regularly, and don't take certain medications that could interfere.
Aurora, ColoradoAges 21–65 - NCT05649059RecruitingPhase 4
Cannabidiol study for social anxiety symptoms
This trial studies whether cannabidiol (CBD) helps improve social anxiety symptoms. You may be able to join if you are an adult with significant social anxiety and meet medication and health safety requirements.
Cambridge, MassachusettsAges 18–55 - NCT07549256RecruitingPhase 2
Cannabidiol for Pain Relief in Advanced Prostate Cancer
This trial tests whether cannabidiol (CBD), a non-intoxicating cannabis compound, can help relieve pain in patients with advanced prostate cancer that has stopped responding to standard treatments. You would take CBD daily alongside your current morphine pain medication.
GistrupAges Any age - NCT06107062RecruitingPhase 2
CBD treatment for cannabis concentrate users
This trial tests CBD as a potential treatment for heavy cannabis concentrate users who want to cut down or quit. You would take CBD daily and attend regular visits to track your progress.
Boulder, ColoradoAges 21 years+ - NCT06569394RecruitingPhase 2
Testing CBD in young adults who use cannabis heavily
This study tests whether cannabidiol (CBD) can help young adults who use cannabis heavily but aren't looking to quit. You'll take a CBD pill and see if it changes your cannabis use or related symptoms.
Aurora, ColoradoAges 18–25 - NCT05020028RecruitingPhase 2/Phase 3
CBD to reduce knee pain from osteoarthritis
This study tests cannabidiol (CBD) to help lower pain from knee osteoarthritis. It may be an option if you have ongoing knee pain and meet age, safety, and medication guidelines.
New York, New YorkAges 40–75 - NCT06994520Enrolling by invitationPhase 2
Topical cannabis extract for eczema itch
This study tests a cannabis-based cream on eczema-related itch over 4 weeks. It may help reduce itching if other treatments haven't worked, but requires pausing other skin products during the trial.
Khon Kaen, Changwat Khon KaenAges 25 years+ - NCT07069478Recruiting
CBD and stress response study
This study looks at how cannabidiol (CBD) affects your body's response to stress. You may be able to help researchers understand if regular CBD use changes how you handle stressful situations.
Minneapolis, MinnesotaAges 21–70 - NCT04411225RecruitingPhase 3
CBD may help early psychosis along with usual treatment
This Phase 3 trial tests whether taking cannabidiol (CBD) can reduce symptoms when added to standard care for early psychosis (like first-episode psychosis or attenuated psychosis). It may help some people have fewer troubling thoughts or perceptions over time.
La Jolla, CaliforniaAges 16–30 - NCT04550377RecruitingPhase 2
Cannabidiol for PTSD, including PTSD after mild head injury
This Phase 2 study tests whether cannabidiol (CBD) can reduce PTSD symptoms, including in people who also had a mild traumatic brain injury (TBI). It’s meant to see if CBD is helpful and safe for PTSD symptoms over the study period.
New York, New YorkAges 18–70 - NCT05015439RecruitingPhase 1
CBD study for adults with autism and challenging symptoms
This Phase 1 study tests cannabidiol (CBD) in adults on the autism spectrum who also have mood, sleep, or behavior problems. The goal is to learn whether CBD can be given safely and may help symptoms that affect daily life.
Baltimore, MarylandAges 18 years+ - NCT05269459RecruitingPhase 2
CBD for PTSD symptoms in adults
This Phase 2 study tests whether cannabidiol (CBD) can safely reduce PTSD symptoms in adults. You may be eligible if you have a current PTSD diagnosis and can follow the study steps for the full time.
Omaha, NebraskaAges 21–65 - NCT05269628RecruitingPhase 2
Cannabidiol for multiple sclerosis sleep and pain patterns
This study looks at whether cannabidiol (CBD, a cannabis-related medicine) can improve symptoms in people with multiple sclerosis (MS), especially how sleep and pain type affect outcomes. It’s mainly for people with MS and ongoing moderate-to-severe pain, while carefully checking safety and medication interactions.
Ann Arbor, MichiganAges 18–65 - NCT05283382RecruitingEarly Phase 1
Cannabidiol trial for learning and anxiety
This early-phase study tests how cannabidiol (CBD) affects learning and anxiety. You may be able to join if you meet age and health requirements and have not used CBD or other cannabis recently.
Storrs, ConnecticutAges 18–50 - NCT05457465RecruitingPhase 2
Cannabidiol study for anxiety and depression in bipolar disorder
This Phase 2 study tests whether cannabidiol (CBD) can reduce anxiety and depressive symptoms in people with bipolar disorder. It may help if your mood symptoms are persistent and you’re already on stable bipolar medications.
Belmont, MassachusettsAges 18–65
What Cannabidiol is being studied for
Conditions with recruiting Cannabidiol studies.
Common questions
- Are there clinical trials studying Cannabidiol?
- Yes. Clin2 currently lists 66 recruiting studies that include Cannabidiol, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Cannabidiol trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Cannabidiol an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Cannabidiol or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.